Experimental combo for tough blood cancers hits early hurdle
Disease control
Terminated
This early-stage trial tested a new drug called DSP107 combined with standard chemotherapy drugs (azacitidine and venetoclax) in 25 people with relapsed or hard-to-treat acute myeloid leukemia, myelodysplastic syndrome, or chronic myelomonocytic leukemia. The study aimed to check…
Phase: PHASE1 • Sponsor: Kahr Medical • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC